143 related articles for article (PubMed ID: 27489147)
21. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
22. The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older.
Kim HJ; Koo HS; Kim YS; Kim MJ; Kim KM; Joo NS; Haam JH
J Bone Miner Metab; 2017 Nov; 35(6):659-665. PubMed ID: 27873076
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosis.
Murugaesu N; Powles T; Bestwick J; Oliver RT; Shamash J
Osteoporos Int; 2009 Sep; 20(9):1627-30. PubMed ID: 19030945
[TBL] [Abstract][Full Text] [Related]
24. Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.
Stelwagen J; Meuleman AT; Lubberts S; Steursma G; Kruyt LM; Donkerbroek JW; Meijer C; Walenkamp AME; Lefrandt JD; Rakers SE; Huitema RB; de Jong MAA; Wiegman EM; van den Bergh ACM; de Jong IJ; van Rentergem JAA; Schagen SB; Nuver J; Gietema JA
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830829
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor.
Wiechno PJ; Kowalska M; Kucharz J; Sadowska M; Michalski W; Poniatowska G; Jońska-Gmyrek J; Rzymkowska J; Nietupski K; Demkow T
Med Oncol; 2017 May; 34(5):84. PubMed ID: 28389909
[TBL] [Abstract][Full Text] [Related]
26. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
27. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of vertebral fractures independent of BMD and anticancer treatment in patients with testicular germ cell tumors.
Willemse PM; Hamdy NA; van Wulften L; van Steijn-van Tol AQ; Putter H; Osanto S
J Clin Endocrinol Metab; 2010 Nov; 95(11):4933-42. PubMed ID: 20702527
[TBL] [Abstract][Full Text] [Related]
30. Endocrinological late effects after chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schuppert F; Schmoll HJ
Br J Cancer; 1996 May; 73(9):1108-14. PubMed ID: 8624272
[TBL] [Abstract][Full Text] [Related]
31. Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells.
Bang AK; Petersen JH; Petersen PM; Andersson AM; Daugaard G; Jørgensen N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):672-6. PubMed ID: 19250763
[TBL] [Abstract][Full Text] [Related]
32. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Kreiberg M; Jørgensen N; Juul A; Lauritsen J; Oturai P; Helge JW; Christensen JF; Aksglaede L; Schauer T; Wagner T; Rosenvilde J; Grunwald E; Dehlendorff C; Daugaard G; Bandak M
Clin Genitourin Cancer; 2022 Oct; 20(5):404-414. PubMed ID: 35701334
[TBL] [Abstract][Full Text] [Related]
33. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
[TBL] [Abstract][Full Text] [Related]
34. Serum 25-hydroxy vitamin D status is not related to osteopenia/osteoporosis risk in colorectal cancer survivors.
Akinci MB; Sendur MA; Aksoy S; Yazici O; Ozdemir NY; Kos T; Yaman S; Altundag K; Zengin N
Asian Pac J Cancer Prev; 2014; 15(8):3377-81. PubMed ID: 24870725
[TBL] [Abstract][Full Text] [Related]
35. Hypogonadism and fertility issues following primary treatment for testicular cancer.
Oldenburg J
Urol Oncol; 2015 Sep; 33(9):407-12. PubMed ID: 25736189
[TBL] [Abstract][Full Text] [Related]
36. Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study.
O'Carrigan B; Fournier M; Olver IN; Stockler MR; Whitford H; Toner GC; Thomson DB; Davis ID; Hanning F; Singhal N; Underhill C; Clingan P; McDonald A; Boland A; Grimison P;
Intern Med J; 2014 Aug; 44(8):813-7. PubMed ID: 25081047
[TBL] [Abstract][Full Text] [Related]
37. The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
Donner DG; Elliott GE; Beck BR; Forwood MR; Du Toit EF
Osteoporos Int; 2016 Mar; 27(3):1073-1082. PubMed ID: 26438310
[TBL] [Abstract][Full Text] [Related]
38. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
39. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
40. Treatment of testicular cancer: influence on pituitary-gonadal axis and sexual function.
Lackner J; Schatzl G; Koller A; Mazal P; Waldhoer T; Marberger M; Kratzik C
Urology; 2005 Aug; 66(2):402-6. PubMed ID: 16040104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
